Technology · Biochemistry & industrial biotech / Enzymes & biocatalysis
Enzymatic polymer synthesis in vitro
Cell-free directed synthesis of high-molecular-weight polymers utilizing purified recombinant enzymes ex vivo, eliminating metabolic constraints to produce ultra-pure biomaterials for regenerative medicine and high-end cosmetics.
1 · What it gives
In vitro enzymatic polymerization represents a revolutionary frontier at the intersection of synthetic biology and materials science. Traditional biopolymer synthesis inside living cells is limited by physiological constraints: cells cannot accumulate excessively long or toxic polymer chains and expend up to 60% of their energy on biomass maintenance. Cell-free synthesis entirely liberates the process from living organisms. Highly purified recombinant enzymes act as precision molecular machines, assembling monomers into polymer chains in mild, aqueous conditions at room temperature. This approach achieves exceptional control over molecular weight distribution, yielding chemically pure polymers devoid of bacterial endotoxins. Such ultra-pure materials are critical for developing resorbable surgical sutures, artificial organ scaffolds, and controlled drug delivery systems.
The key directions of in vitro enzymatic polymer synthesis are:
- Cell-free Polysaccharide Synthesis: Stepwise assembly of alpha-1,4-glucan or beta-1,4-glucan molecules using purified phosphorylases and synthases.
- Lipase-catalyzed Polyester Synthesis: Production of aliphatic polyesters (e.g., polycaprolactone) in non-aqueous media using immobilized enzymes.
- Enzyme Engineering: Utilizing artificial intelligence and high-throughput robotic screening to design hyperactive polymerases.
- Downstream Purification: Industrial-scale chromatographic separation to isolate completely homogenous enzymes for medical-grade synthesis.
Sectoral value chain#
[Recombinant expression] ──> [Enzyme purification] ──> [In vitro polymerization] ──> [Polymer precipitation]
│
(Activated monomers)
│
▼
[B2B biomaterials] <─── [Drying & QC] <─────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Recombinant expression | Microbial production of polymerizing enzymes. | In: Sugar substrate. Out: Cell lysate. |
| Enzyme purification | Downstream processing to a homogenous state. | In: Cell lysate. Out: Purified enzyme. |
| In vitro polymerization | Ex vivo reaction of enzymes and activated monomers. | In: Enzyme + monomers. Out: Polymer solution. |
| Polymer precipitation | Controlled solvent addition and filtration. | In: Polymer solution. Out: Precipitated polymer. |
| Drying & QC | Vacuum drying and molecular weight validation. | In: Precipitated polymer. Out: Pure polymer granules. |
| B2B biomaterials | Manufacturing of medical scaffolds and sutures. | In: Pure polymer granules. Out: Medical devices. |
Cross-cutting technologies of the sector:
- Immobilized biocatalysis: Securing enzymes to solid supports to enhance stability in organic solvents.
- Size Exclusion Chromatography: Multi-angle light scattering validation of exact polymer chain lengths.
- Directed evolution: Iterative improvement of enzyme catalytic efficiency for industrial scalability.
2 · What it replaces 6 · matched by industry
3 · How to implement 6 steps
- 1Substrate preparationFormulation & blendingGlucose-1-phosphate and short oligosaccharide primers are dissolved in deionized water buffered to pH 6.8 within a polished stainless steel or glass-lined biocatalytic reactor.Who can do this step matched automatically✓ ISO 9001 500 m3“This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”Rossari Biotech (NSE) India✓ ISO 9001 industrial scale“The company also announced a new greenfield blending facility in Thailand to boost Southeast Asia operations and smarter capacity utilization across its HPPC, TSC, and AHN …”
- 2Enzyme additionA highly purified preparation of recombinant alpha-glucan phosphorylase, strictly free from host-cell endotoxins and stray proteins, is introduced into the sterile reaction mixture.
- 3Polymerization & shiftSynthesis & conversionThe mixture is thermostatted at 37°C while the enzyme sequentially transfers glucose residues to the primer, with barium hydroxide or ion-exchange resins added to precipitate phosphate and drive the reaction forward.Who can do this step matched automaticallyRossari Biotech (NSE) India✓ ISO 9001 industrial scale“A liver protectant comprising a combination of Liver extracts, Choline chloride, Inositol, Vitamin B12, Protein Hydrolysate, Biotin, Selenium, Vitamin E and Methylsulfonylmethane.”SyncoZymes (Shanghai) China1,200 tons industrial scale“is a biotechnology company specializing in green pharmaceutical technology, biocatalysis, and synthetic biology.”Bota Bio 恩和生物 China✓ ISO 9001 600 tons pilot scale“Protein expression is limited by multiple bottlenecks, such as transcription efficiency, translation efficiency, metabolic constraints, protein folding, and hydrolysis.”
- 4Polymer precipitationUpon reaching the targeted molecular weight, the synthesized high-molecular-weight glucan is abruptly precipitated by introducing food-grade ethanol to halt the enzymatic activity.
- 5Drying & QC validationTesting & analyticsPurification & downstreamThe precipitate is separated via centrifugation, washed with Water for Injection (WFI), vacuum-dried, and analyzed via SEC-MALLS to confirm the exact molecular weight distribution.Who can do this step matched automatically✓ ISO 9001 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”SyncoZymes (Shanghai) China1,200 tons industrial scale“CRO/CDMO and Testing/Quality Research Services: Comprehensive contract research and development, analytical, and quality assessment capabilities with access to NMR, LC-MS, GC-MS, …”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”BRAIN Biotech Germany✓ ISO 9001 industrial scale“As a contract research organization (CRO), we provide smart, rapid, and effective solutions using cutting-edge technologies to drive customer success.”Keclon Argentina60,000 liters industrial scale“Maximize volumetric productivity and downstream processing at pilot scale”
- 6Aseptic packagingPackaging & fill-finishThe finished, ultra-pure polymer is packaged into double aseptic bags within an ISO Class 5 cleanroom environment, utilizing Swagelok connectors to maintain absolute sterility for B2B medical clients.Who can do this step matched automaticallyIndia Glycols (NSE) India✓ ISO 9001 7,500 MT/ industrial scale“Key partners/customers mentioned: Bacardi bottling tie-up; JV with Clariant; tech partnerships with Wittemann, Hitachi, Air Liquide and Praxair; global/brand partnerships …”Stora Enso Finland✓ ISO 9001 industrial scale“Together with our customers, we design and deliver competitive, high-quality packaging materials and solutions, made from fresh and recycled fibers, accelerating the transition to …”RWDC Industries Singaporeindustrial scale“2026-04-02 [A Major Step Forward in the Fight Against Microplastics — RWDC Industries is positioning itself as a leader in sustainable biopolymers, specifically Solon PHA, a fully …”
4 · Who delivers
Matched suppliers (matched automatically)
| Novonesis | Denmark | Producer | active |
| Codexis | United States | Producer | active |
| Evonik | Germany | Producer | active |
| Ginkgo Bioworks | United States | Producer | active |
| Toyobo | Japan | Producer | active |
In the services and supply catalogue 2 · paid service
Contract manufacturing (CMO/CDMO/toll) · Enzymes & biocatalysts
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Codexis | 🇺🇸 USA | Engineered enzymes | Directed evolution platforms | commercial |
| Evonik Industries | 🇩🇪 Germany | Medical PLGA | Biocatalytic polyester synthesis | commercial |
| TIB (CAS) | 🇨🇳 China | Synthetic polysaccharides | Multi-enzyme in vitro cascades | operating |
| Ginkgo Bioworks | 🇺🇸 USA | Foundry platforms | Custom cell-free polymerization | commercial |
| Novonesis | 🇩🇰 Denmark | Novozym 435 | Immobilized industrial lipases | commercial |
| Buchi AG | 🇨🇭 Switzerland | Reactor systems | Glass-lined biocatalytic reactors | commercial |
5 · Rules & route to market
Route into Russia / EAEU: CHEM · Minpromtorg (registration) / Rospotrebnadzor (notification of new substances)
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The United States leads the global commercialization of cell-free protein and polymer synthesis platforms, leveraging massive biotech foundry infrastructure.
Enzyme engineering, Cell-free platforms, FDA validation#
- Directed evolution leadership: American SynBio giants (Codexis, Ginkgo Bioworks) utilize AI-driven enzyme design and high-throughput robotics to engineer hyperactive lipases and synthases.
- Ultra-pure food films: Rapid growth in startups producing ultra-pure amylose for biodegradable food packaging barriers.
- Medical guidelines: The FDA has established specific validation guidelines for cell-free medical materials, emphasizing the complete absence of microbial endotoxins and heavy metals.
European Union
The European Union approaches in vitro synthesis primarily through the lens of green chemistry and the development of highly biocompatible medical materials.
Biocompatible polymers, Green chemistry, Heavy-metal elimination#
- Catalyst replacement: European chemical leaders like Evonik actively use immobilized enzymes (such as CALB) to synthesize polyesters and cosmetic polyols with absolutely zero heavy metal residues.
- Regulatory pressure: The EU strictly regulates the use of toxic tin catalysts in traditional polyurethane and polyester production, creating a powerful market incentive for enzymatic alternatives.
- Medical innovation: Strong R&D focus on utilizing pristine, heavy-metal-free bio-polymers for regenerative medicine and tissue engineering scaffolds.
China
China focuses on the industrial scale-up of cell-free enzymatic synthesis, rapidly driving down costs to make highly engineered polysaccharides commercially viable.
Multi-enzyme cascades, CO2 utilization, Scale-up manufacturing#
- Academic-industrial integration: The Tianjin Institute of Industrial Biotechnology (TIB) has developed unique multi-enzyme cascades that convert cheap starch or CO2 directly into high-value polysaccharides in vitro.
- Chromatography scale-up: China leads in the mass production of large-scale chromatographic columns necessary for the affordable downstream purification of synthesis enzymes.
- B2B cost parity: Focused state investments aim to bring the cost of cell-free polysaccharide synthesis down to competitive B2B levels for mass market applications.
6 · Money: tenders & grants
| Grant | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals European Commission · EU | Apr 13, 2027 179 days |
| Grant | Advancing bio-printing of living cells for regenerative medicine European Commission · EU | Sep 22, 2027 341 days |
| Grant | Research and Development (RAD) Directed Energy (RD) University Assistance Instruments Air Force -- Research Lab · United States | Jul 18, 2029 1006 days |
7 · Tech stack & innovations
In vitro polymer synthesis relies on the absolute control of enzymatic environments, eliminating cellular noise to achieve mathematically precise molecular assemblies.
- Enzymatic Catalysis:
- Alpha-glucan phosphorylase (derived from Solanum tuberosum or E. coli) drives the precise linkage of glucose-1-phosphate onto oligosaccharide primers.
- Immobilized Candida antarctica lipase B (CALB) catalyzes polyester synthesis in non-aqueous or supercritical CO2 environments without the need for toxic metal catalysts.
- Analytical Validation:
- Multi-Angle Light Scattering combined with Size Exclusion Chromatography (SEC-MALLS) validates the exceptionally narrow molecular weight distribution characteristic of cell-free synthesis.
- Endotoxin Control:
- Limulus Amebocyte Lysate (LAL) assays confirm the complete sterility and purity of the resulting polymers, enabling immediate classification for Class III medical device applications.
Sources 6 · 0 independent · 6 producer sites
Producers' own sites 6
- Codexis producer checked 2025-10-16 · link not kept
- Evonik producer checked 2025-06-10 · link not kept
- Tib cas producer checked 2026-06-25 · link not kept
- Ginkgo bioworks producer checked 2025-06-09 · link not kept
- Novonesis producer checked 2026-01-19 · link not kept
- Buchi ag producer checked 2026-08-09 · link not kept